Evaluation of Efficacy and Safety of Gynomax® XL Ovule
Status:
Completed
Trial end date:
2019-08-09
Target enrollment:
Participant gender:
Summary
Efficacy and safety of Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial
vaginosis, candidal vulvovaginitis and mixed vaginal infections will be evaluated in this
open label, single-arm, multicentral study.